Sertindole
- Generic Name
- Sertindole
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H26ClFN4O
- CAS Number
- 106516-24-9
- Unique Ingredient Identifier
- GVV4Z879SP
- Background
Sertindole, a neuroleptic, is one of the newer antipsychotic medications available. Serdolect is developed by the Danish pharmaceutical company H. Lundbeck. It is a phenylindole derivative used in the treatment of schizophrenia. It was first marketed in 1996 in several European countries before being withdrawn two years later because of numerous cardiac adve...
- Indication
Used in the treatment of schizophrenia.
- Associated Conditions
- Schizophrenia
- Associated Therapies
- -
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2014-05-28
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 264
- Registration Number
- NCT00654706
- Locations
- ๐บ๐ธ
US012, Baltimore, Maryland, United States
๐บ๐ธUS020, Dallas, Texas, United States
๐บ๐ธUS014, Stanford, California, United States
The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 14
- Registration Number
- NCT00629252
- Locations
- ๐จ๐ญ
University Hospital of Psychiatry, Department Neuropsychopharmacology and Brain Imaging, Zurich, ZH, Switzerland
The Effect of Sertindole on Sensory Gating and Cognition in Healthy Volunteers
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 30
- Registration Number
- NCT00612079
- Locations
- ๐จ๐ญ
University of Psychiatry Hospital, Zurich, ZH, Switzerland
Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT00480844
- Locations
- ๐ฎ๐ฑ
Department of Psychiatry of the Sheba Medical Center, Ramat Gan, Tel Hashomer, Israel
๐ฎ๐ฑKfar Shaul Mental Health Center, Jerusalem, Israel
๐ฎ๐ฑBeer-Yaakov Mental Health Center, Beer-Yaakov, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.